51.14

3.27% 1.62

After Hours: 51.14

Twist Bioscience Corp (TWST)

Overview News Price History Option Chain Financials Discussions Forecast

Twist Bioscience Corp stock is traded at $51.14, with a volume of 706.65K. It is up +3.27% in the last 24 hours and up +8.28% over the past month. Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

Previous Close:

$49.52

Open:

$50.25

24h Volume:

706.65K

Relative Volume:

0.91

Market Cap:

$3.05B

Revenue:

$277.49M

Net Income/Loss:

$-192.14M

P/E Ratio:

-15.22

EPS:

-3.36

Net Cash Flow:

$-95.52M

1W Performance:

-4.05%

1M Performance:

+8.28%

6M Performance:

-8.47%

1Y Performance:

+54.04%

1-Day Range:

$50.25

$52.90

1-Week Range:

$49.40

$55.33

52-Week Range:

$27.41

$60.90

Twist Bioscience Corp Stock (TWST) Company Profile

Name

Twist Bioscience Corp

Sector

Healthcare (1174)

Industry

Diagnostics & Research (59)

Phone

800-719-0671

Address

681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA

Employee

923

Twitter

@TwistBioscience

Next Earnings Date

2024-11-18

Latest SEC Filings

TWST's Discussions on Twitter

Compare TWST with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TWST Twist Bioscience Corp	51.14	3.05B	277.49M	-192.14M	-95.52M	-3.36
TMO Thermo Fisher Scientific Inc	606.74	232.08B	42.37B	6.14B	7.78B	15.95
DHR Danaher Corp	223.08	160.42B	23.74B	3.89B	4.98B	5.24
A Agilent Technologies Inc	151.38	42.01B	6.51B	1.29B	1.37B	4.42
IQV Iqvia Holdings Inc	201.78	36.62B	15.32B	1.41B	1.96B	7.62
IDXX Idexx Laboratories Inc	423.99	34.72B	3.84B	866.24M	792.60M	10.37

Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-13-24	Initiated	Wolfe Research	Outperform
Jun-04-24	Initiated	Guggenheim	Buy
Jan-17-24	Upgrade	Goldman	Neutral → Buy
Sep-27-23	Initiated	Berenberg	Buy
Jan-05-23	Initiated	Scotiabank	Sector Outperform
Jan-03-23	Upgrade	Evercore ISI	In-line → Outperform
Mar-02-22	Resumed	Cowen	Outperform
Oct-15-21	Resumed	Cowen	Outperform
Jun-29-21	Initiated	William Blair	Outperform
Jun-04-21	Initiated	Goldman	Neutral
Apr-12-21	Initiated	Piper Sandler	Overweight
Feb-05-21	Downgrade	JP Morgan	Neutral → Underweight
Jan-04-21	Downgrade	Evercore ISI	Outperform → In-line
Oct-20-20	Initiated	SVB Leerink	Mkt Perform
May-31-19	Initiated	Evercore ISI	Outperform
Nov-26-18	Initiated	JP Morgan	Neutral

View All

Twist Bioscience Corp Stock (TWST) Latest News

Jan 27, 2025

Twist Bioscience Co. (NASDAQ:TWST) COO Sells $121,511.74 in Stock - MarketBeat

Jan 27, 2025

Jan 22, 2025

Twist Bioscience to Report Fiscal 2025 First Quarter Financial Results on Monday, February 3, 2025 - Business Wire

Jan 22, 2025

Jan 20, 2025

RNA Transcriptome Profiling Tests Market Expands at 14.5% CAGR, Surpassing US$ 37 Billion by 2034 | Fact.MR Report - GlobeNewswire Inc.

Jan 20, 2025

Avanza Fonder AB Buys New Position in Twist Bioscience Co. (NASDAQ:TWST) - MarketBeat

Jan 20, 2025

Jan 15, 2025

Twist Bioscience (NASDAQ:TWST) Trading Up 9.5%What's Next? - MarketBeat

Jan 15, 2025

Jan 14, 2025

Insider Selling: Twist Bioscience Co. (NASDAQ:TWST) CFO Sells 5,886 Shares of Stock - MarketBeat

Jan 14, 2025

Twist Bioscience CFO Adam Laponis sells $254,646 in stock - Investing.com

Jan 14, 2025